Edgewise Therapeutics (EWTX) Insider Trading & Ownership $22.80 -0.57 (-2.44%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$22.85 +0.05 (+0.22%) As of 08:51 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Edgewise Therapeutics (NASDAQ:EWTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.11%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$12.74 M Get EWTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Edgewise Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EWTX Insider Buying and Selling by Quarter Remove Ads Edgewise Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/6/2025Alan J RussellInsiderSell1,200$30.13$36,156.00 2/5/2025Kevin KochCEOSell8,636$30.03$259,339.08 1/28/2025Joanne M DonovanCMOSell25,000$27.63$690,750.00 12/30/2024Alan J RussellInsiderSell100,000$27.37$2,737,000.00 12/24/2024Marc SemigranInsiderSell29,709$29.69$882,060.21 9/23/2024John R MooreGeneral CounselSell20,922$27.63$578,074.86 9/20/2024Alan J RussellInsiderSell75,000$28.27$2,120,250.00 9/20/2024Joanne M DonovanCMOSell7,162$28.29$202,612.98 9/20/2024John R MooreGeneral CounselSell50,000$28.37$1,418,500.00 9/20/2024R Michael CarruthersCFOSell125,092$28.57$3,573,878.44 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/2/2024Behrad DerakhshanInsiderSell1,718$18.91$32,487.38 5/2/2024Joanne M DonovanCMOSell3,682$18.91$69,626.62 5/2/2024John R MooreGeneral CounselSell1,956$18.91$36,987.96 5/2/2024Kevin KochCEOSell3,152$18.91$59,604.32 5/2/2024R Michael CarruthersCFOSell2,157$18.91$40,788.87 (Data available from 1/1/2013 forward) EWTX Insider Trading Activity - Frequently Asked Questions Who is on Edgewise Therapeutics's Insider Roster? The list of insiders at Edgewise Therapeutics includes Alan J Russell, Behrad Derakhshan, Holdings A/S Novo, Joanne M Donovan, John R Moore, Jonathan C Fox, Kevin Koch, Marc Semigran, Orbimed Advisors Llc, Peter A Thompson, and R Michael Carruthers. Learn more on insiders at EWTX. What percentage of Edgewise Therapeutics stock is owned by insiders? 24.11% of Edgewise Therapeutics stock is owned by insiders. Learn more on EWTX's insider holdings. Which Edgewise Therapeutics insiders have been buying company stock? The following insiders have purchased EWTX shares in the last 24 months: Jonathan C Fox ($100,970.10), and Peter A Thompson ($4,999,995.00). How much insider buying is happening at Edgewise Therapeutics? Insiders have purchased a total of 465,402 EWTX shares in the last 24 months for a total of $5,100,965.10 bought. Which Edgewise Therapeutics insiders have been selling company stock? The following insiders have sold EWTX shares in the last 24 months: Alan J Russell ($6,503,624.05), Behrad Derakhshan ($140,081.68), Joanne M Donovan ($991,950.20), John R Moore ($2,050,446.12), Kevin Koch ($347,450.10), Marc Semigran ($882,060.21), and R Michael Carruthers ($5,046,757.71). How much insider selling is happening at Edgewise Therapeutics? Insiders have sold a total of 768,527 Edgewise Therapeutics shares in the last 24 months for a total of $16,572,108.86 sold. Edgewise Therapeutics Key ExecutivesDr. Peter A. Thompson FACP (Age 64)M.D., Co-Founder & Independent Chairman Compensation: $76kDr. Kevin Koch Ph.D. (Age 64)President, CEO & Director Compensation: $905.52kDr. Badreddin Edris Ph.D. (Age 37)Co-Founder & Independent Director Compensation: $43kDr. Behrad Derakhshan Ph.D. (Age 44)Chief Business Officer Compensation: $630.67kDr. Joanne M. Donovan M.D. (Age 67)Ph.D., Chief Medical Officer Compensation: $696.4kDr. Alan J. Russell Ph.D. (Age 54)Co-Founder, Chief Scientific Officer & Director Compensation: $657.52kMr. R. Michael Carruthers (Age 66)Chief Financial Officer Compensation: $386.01kMr. John R. Moore (Age 60)General Counsel Dr. Marc Semigran M.D. (Age 67)Chief Development Officer More Insider Trading Tools from MarketBeat Related Companies SRPT Insider Ownership PCVX Insider Ownership ROIV Insider Ownership RVMD Insider Ownership LNTH Insider Ownership TGTX Insider Ownership BBIO Insider Ownership AXSM Insider Ownership BPMC Insider Ownership GRFS Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:EWTX) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EWTX Stock Free EWTX Stock Alerts